SCHEMBL17018657

SCHEMBL17018657

CNc1nc(Nc2cc(C)cc(C)c2)nc(Nc2cccc(C=O)c2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH2 P48735 1/20 0.49
NFKB1 P19838 1/20 0.44
PTK2 Q05397 1/20 0.43
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
KCNH3 Q9ULD8 1/20 0.42
POLB P06746 2/20 0.41
TNNI3K Q59H18 1/20 0.41
SLC2A1 P11166 1/20 0.40
EGFR P00533 2/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.39
TERT O14746 1/20 0.39
AURKA O14965 1/20 0.39
ITK Q08881 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4568646 0.87 NFKB1 (0.58) NFKB1LMNAKCNH3POLBTNNI3K
SCHEMBL4544806 0.77 NFKB1 (0.69) NFKB1LMNAKCNH3POLBTNNI3K
SCHEMBL17018656 0.77 RHOA (0.68) IDH2CA12CA2CA9TP53
SCHEMBL13401823 0.77 NFKB1 (0.56) NFKB1LMNAKCNH3POLBTNNI3K
SCHEMBL15403837 0.77 KCNH3 (0.57) IDH2KCNH3CA1CA2CA9
SCHEMBL17018662 0.76 SYK (0.51) IDH2NFKB1LMNAGAAKCNH3
SCHEMBL17018659 0.76 IDH2 (0.49) IDH2NFKB1PTK2LMNAGAA
SCHEMBL17714638 0.74 IDH2 (0.44) IDH2LMNAGAACA12CA1
SCHEMBL14583173 0.73 NFKB1 (0.63) NFKB1LMNAKCNH3POLBTNNI3K
SCHEMBL19101480 0.73 RAB9A (0.66) IDH2NFKB1LMNAGAAKCNH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9346768-B2 Molecular glasses with functionalizable groups HER MAJESTY THE QUEEN IN RIGHT OF CANADA AS REPRESENTED BY THE MINISTER OF NATIONAL DEFENSE (CA) 2016-05-24 US disclosed
US-9346768-B2 Molecular glasses with functionalizable groups HER MAJESTY THE QUEEN IN RIGHT OF CANADA AS REPRESENTED BY THE MINISTER OF NATIONAL DEFENSE (CA) 2016-05-24 US disclosed
US-9328076-B2 Molecular glasses with functionalizable groups HER MAJESTY IN THE RIGHT OF CANADA AS REPRESENTED BY THE MINISTER OF DEFENSE (CA) 2016-05-03 US disclosed
US-9328076-B2 Molecular glasses with functionalizable groups HER MAJESTY IN THE RIGHT OF CANADA AS REPRESENTED BY THE MINISTER OF DEFENSE (CA) 2016-05-03 US disclosed
US-20150232433-A1 Molecular Glasses With Functionalizable Groups HER MAJESTY THE QUEEN IN RIGHT OF CANADA AS REPRESENTED BY THE MINISTER OF NATIONAL DEFENCE (CA) 2015-08-20 US disclosed
US-20150232433-A1 Molecular Glasses With Functionalizable Groups HER MAJESTY THE QUEEN IN RIGHT OF CANADA AS REPRESENTED BY THE MINISTER OF NATIONAL DEFENCE (CA) 2015-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150232433-A1 Molecular Glasses With Functionalizable Groups GDI1, GNG2, F12 IDH2 3489/4885NFKB1 1431/4885PTK2 415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.